VIA
DNTH icon

Virtus Investment Advisers’s Dianthus Therapeutics DNTH Stock Holding History

Virtus Investment Advisers’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Sell
3,987
-2,485
-38% -$217K 0.09% 293
2026
Q1 		$543K Buy
6,472
+157
+2% +$9.09K 0.15% 208
2025
Q4 		$260K Buy
6,315
+416
+7% +$16.1K 0.07% 312
2025
Q3 		$232K Buy
5,899
+1,024
+21% +$26.2K 0.07% 247
2025
Q2 		$90.8K Sell
4,875
-2,111
-30% -$39.6K 0.03% 374
2025
Q1 		$127K Buy
+6,986
New +$154K 0.03% 383

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Virtus Investment Advisers's DNTH Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Dianthus Therapeutics (DNTH) stake by 38% in Q2 2026, selling an estimated $217K and leaving 3,987 shares worth $389K. The position accounts for 0.09% of the portfolio, ranked #293.

Virtus Investment Advisers first reported a position in DNTH in Q1 2025 and has held it in 6 quarters since. The position peaked at $543K in Q1 2026. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Virtus Investment Advisers held 3,987 shares of Dianthus Therapeutics worth $389K as of Q2 2026.
  • Virtus Investment Advisers sold 2,485 Dianthus Therapeutics shares in Q2 2026, an estimated $217K.
  • Dianthus Therapeutics made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #293 holding.
  • Virtus Investment Advisers first reported a position in Dianthus Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Virtus Investment Advisers's Dianthus Therapeutics position peaked at $543K in Q1 2026.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.